Fennec Pharmaceuticals: Great Sales Progress - Not Yet Reflected In Stock Price

FatCamera Fennec Pharmaceuticals – Revenue Guidance and EU Launch Fennec Pharmaceuticals (NASDAQ:FENC) (the Company), is a small cap, commercial-stage biotech company with a single drug, PEDMARK®. PEDMARK is a unique formulation of sodium thiosulfate specifically developed for pediatric patients. PEDMARK is FDA-approved to reduce the risk of ototoxicity or hearing loss associated with cisplatin in pediatric patients 1 month of age and older with localized, non-metastatic solid tumors. The drug is used i ...